Silence Therapeutics plc (NASDAQ:SLN – Free Report) – Analysts at HC Wainwright decreased their FY2024 earnings estimates for ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Free Report) – Equities research analysts at HC Wainwright raised their FY2024 EPS ...

We recently compiled a list of the 10 Trending AI Stocks That Analysts Are Monitoring. In this article, we are going to take ...

We recently compiled a list of the 10 Trending AI Stocks on Wall Street’s Radar. In this article, we are going to take a look ...

H.C. Wainwright analyst Mitchell Kapoor initiated coverage of Crispr Therapeutics (CRSP) with a Buy rating and $65 price target The firm says ...

H.C. Wainwright lowered the firm’s price target on Xoma (XOMA) to $104 from $123 and keeps a Buy rating on the shares. The firm removed ...

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $80.00 price target on Beam Therapeutics Inc ...

H.C. Wainwright reaffirmed a Buy rating and a $14.00 price target on Evaxion Biotech (NASDAQ:EVAX), following the company's recent successful public offering. The stock currently trades at $2.45, down ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

H.C. Wainwright has recently reiterated BigBear.ai Holdings Inc (BBAI) stock to Buy rating, as announced on December 30, 2024, according to Finviz. Earlier, on January 9, 2024, Cantor Fitzgerald had ...